понедельник, 8 октября 2012 г.

HOUSING VISIONS EYES HOME OF ITS OWN.(News) - The Post-Standard (Syracuse, NY)

Byline: Maureen Nolan Staff writer

Housing Visions Unlimited wants to build itself some new space in the East Side neighborhood where it has renovated and constructed affordable housing for years.

The nonprofit agency plans to construct a roughly $1 million maintenance garage and offices on East Fayette Street at Pine Street. That's next to the East Side Business Center, owned by a limited liability corporation controlled by Housing Visions. The project needs site plan approval from the city Planning Commission to move forward.

Housing Visions needs the new 8,000-square-foot building because the agency has grown, said Michael LaFlair, development project manager. The building will contain storage, office space and an exercise room for its construction and maintenance staff, he said.

Housing Visions has added some 15 people in the last year and has a staff of about 100, said Rebecca Newman, director of property management.

The agency usually does 25 to 50 units a year, but at the moment has 78 units under construction, LaFlair said. The projects are the Prospect Hill Homes near St. Joseph's Hospital Health Center and Loguen Homes, near the site of the proposed new building.

The new garage will be designed to blend in with the Business Center and its doors will not face a street. The office section will match the design of nearby Loguen Homes, LaFlair said.

The new building will not be exempt from city property taxes, Newman said.

воскресенье, 7 октября 2012 г.

The eyes are the windows to wellness; Vision benefit plans can pay extra dividends through prompting action on diabetes, hypertension, cholesterol.(Feature Story) - Employee Benefit News

Byline: Susan Egbert and Richard Stolz

Routine eye care facilitated by employee exploitation ofvision care benefits can be a vital adjunct to standard employee health promotion efforts, helping to detect and address serious clinical conditions beyond those pertaining exclusively to eye care, recent research shows.

The new data, which covers both clinical issues and their financial implications for employers, adds a new twist to the existing robust body of evidence of the adverse economic impact of vision-related health conditions. It points to the importance of careful design of vision benefit plans, as well as the effective promotion of such plans to employees so that both health and financial benefits can be gained by employees and employers alike.

The study, performed by Human Capital Management Services, a Wyoming-based data analytics and consulting firm, and commissioned by VSP Vision Care, focused on the detection of diabetes, hypertension and high cholesterol by optometrists before those conditions were identified by other health care providers, particularly patients' primary care physicians.

Given the fact that many employees and their dependents have these conditions without being aware of it in their initial stages, the more health care professionals (whatever their medical specialty) who have an opportunity to detect them, the better. For example, nearly one-fourth of the 24 million Americans believed to have diabetes are oblivious to that fact, according to the Centers for Disease Control and Prevention. From an eye disease perspective, diabetes causes a condition known as diabetic retinopathy, damaging the retina leading to vision impairment if left untreated.

wSimilarly, hypertension and high cholesterol, with their potentially deadly consequences, are often unknown to those who have the conditions. Optometrists routinely detect them, according to optometrist Dr. Michael Johnson, of Eagle Vision Eye Care in Sacramento, Calif.

Proper eye exams, he says, include examination of blood vessels of the eye. 'Diabetes,' he says, 'would most easily be seen by bleeding in the back of the eye.

'For early onset, we'd see small 'dot hemorrhages' - just a little pinpoint of blood. Where it's located in the eye would determine the level of referral that is needed. If you see it just in the periphery of the eye, that would be something we'd watch. As it gets closer to the macula, that would require referral.'

Hypertension, he adds, is evident to an optometrist through detection of 'tortuosity of the blood vessel - it looks like a kinked hose,' he says. 'We also look for how the blood vessels cross each other;' certain patterns can reflect the damaging impact of high blood pressure. (Eye exams may also be accompanied by standard blood pressure checks, Dr. Johnson notes.)

And optometrists can see evidence of high cholesterol levels, according to Dr. Johnson, 'because people with high cholesterol throw off plaque from their carotid artery, and often it will get stuck in the bifurcations, or forks, of the blood vessels in the back of the eye. We'll see a bright refractile material stuck in that bifurcation.' Doctors may also see a grayish-white ring around the cornea called arcus senillis or corneal arcus.

The potential of eye exams to flag fundamental health problems is perhaps even more compelling when viewed in the broader context of workforce demographic trends and their implications for employees' eye care needs. The aging of the baby boomer generation, for example, is expected to lead to a doubling of the number of people experiencing vision-related problems, with consequences not only for their health, but boomers' productivity at the workplace. And, because the eyes are the only place on the body through which blood vessels can be viewed, the opportunity to identify other health issues is further perpetuated.

Visual stress

And simple 'visual stress,' according to the American Optometric Association, 'is a common occurrence in today's visually demanding world' - and not just for older workers. Manifestations of 'visual stress' include regular headaches, diminished focusing power, intermittent blurring and loss of concentration, according to the AOA.

The negative business and personal impacts of these problems have, of course, encouraged most midsized and large employers to make vision benefits available to their employees. A study by Prevent Blindness America, for example, estimated the national annual price tag for adult vision problems at $51.4 billion. That 2007 study included the impact of diabetic retinopathy, the condition optometrists often identify to alert patients to its broader health implications.

Eye doctors' clinical skills that allow them to identify health issues such as diabetes, hypertension and high cholesterol is one matter. But ensuring that patients connect with their primary care physicians to address these conditions, of course, is critical to having a positive outcome. Sophisticated imaging equipment can play a useful role towards that end, according to Dr. Johnson.

'The nice thing about having the kind of equipment I have,' he says, 'is that I can show patients what I'm seeing, like blood in their back of their eye. It makes it more real to them.'

It is the responsibility of patients to take appropriate steps with the primary care provider to address the medical issue identified in the eye exam. But Dr. Johnson says that if he has any concerns about what will happen after the patient leaves his office, he will contact that patient's primary care physician. Relaying clinical information to other health care providers is facilitated, he says, by automation.

'We use a system that makes it very easy to communicate' essential clinical information both to patients and other health care professionals. 'We can print it out and give it to the patient and fax it to the primary care doctor, and know that they're getting all the information they need to move forward.'

The benefits of this kind of communication, according to the HCMS study, can be substantial - especially considering the high human and economic cost of diabetes, hypertension and diabetes. The study, using a HIPAA-compliant process, compared clinical and financial claims data of patients with VSP coverage, to a broader patient universe.

VSP Eye Health Management Program

In 2005, VSP launched a program called the VSP Eye Health Management Program, which requires the eye care professionals in its provider network to report patients with early signs of diabetes, diabetic retinopathy, hypertension, corneal arcus (a symptom of high cholesterol), macular degeneration and glaucoma.

The study concluded that, of all early detections, these optometrists identified 20% of diabetes cases, 30% of hypertension cases and 65% of high cholesterol cases, before they were identified by patients' other care providers, and before the employee self-reported the condition in a personal health assessment survey. A potentially key factor in this result is the fact that workers with vision benefits receive eye exams more frequently than they receive annual preventive exams. Specifically, only 21% of adults receive an annual preventive health exam, but 61% of Americans with vision coverage receive annual eye exams, according to a study reported in the Annals of Internal Medicine.

Impacts of early detection of these health conditions by the eye exams, according to the HCMS study, include the following:

* Health care and pharmacy costs and comorbid conditions were significantly lower in the early detection group, perhaps because later care and treatment typically is more costly.

* Lost-time costs for short-term disability, long-term disability and workers' comp generally were lower for the early detection group.

* Early detection group members were half as likely to terminate their employment during the year following detection of the heath issue. One possible cause of this result may be later detection of health condition leading to increased comorbidity and more extensive treatments, ultimately leading to loss of employment.

Pennies on the dollar

HCMS analysts estimated the purely economic benefits (measuring medical costs, lost time and human capital costs) of providing this type of vision benefits equate to 94 cents of additional value for every dollar spent on vision exams. The biggest savings, according to the study, resulted from the early detection of diabetes.

The overall savings figure suggests that the net cost of every employer dollar invested in a vision benefit - assuming the eye care professionals participating in the plan provide comprehensive eye exams and report relevant findings to primary care providers, along the lines of the VSP program - might be as low as 6 cents.

But employees must take advantage of vision benefits in order for them and their employers to reap the potential health and financial rewards.

While employees with common vision impairments, such as myopia,typically don't need to be encouraged to take advantage of a vision benefit plan, others often do; ignorance on eye health is widespread. For example, a 2006 survey by the National Eye Institute revealed that only 8% of respondents were aware that glaucoma has no early warning signs.

Such data suggests that many employees who don't perceive that they have a need for eye care might fail to appreciate the importance of routine examinations.

The following approaches can significantly increase employee participation in vision benefit programs:

* Provide employee workshops. Use vision plan materials to educate employees on the importance and value of vision care for themselves and their dependents. Use available materials to host a brown-bag or workshop session on the vision benefit.

* Partner with your representative. If possible, bring in a vision plan representative to discuss the value of their benefit with the employees and answer their questions about coverage.

* Remind employees that these benefits are pretax. This reminder increases savings over vision exams and materials purchased without a plan.

Maximum employee participation in vision benefit plans, coupled with a system enabling eye care professionals to communicate easily and effectively with plan members and their primary care providers when conditions such as diabetes, hypertension and high cholesterol are evident, can ensure a high return on employers' investment in vision benefits.

Vision Center Eye Doctor Expands Pediatric Care to Orange County Residents. - Clinical Trials Week

The center will schedule patients for ophthalmic care in children Tuesdays and Wednesdays starting on Nov. 9 said Dr. Reiser, who also serves as an assistant professor of clinical ophthalmology at the Keck School of Medicine of the University of Southern California (USC) and attending physician at Doheny Eye Institute (see also Blindness).

Additionally, eye surgeons will perform the Trabectome procedure, which is a minimally invasive technique for treating open-angle glaucoma, and will be one of only three centers in the world offering the new Boston Scleral Lens Prosthetic Device, a procedure that can improve vision, reduce painful irritation in dry-eyed patients who are otherwise contact-lens intolerant.

'This new center will give Orange County families and their children access to our state-of-the-art eye care services and procedures in their community,' said Dr. Reiser. 'I am excited to be a part of this wonderful venture which allows The Vision Center and fellow USC ophthalmologists to reach out and help more families in Southern California with the same mission in mind - prevent blindness in children.'

The facility will include eight exam lanes and a state-of-the-art procedure room for noninvasive treatments. Surgeries will be performed in the Pavilion's Orange Coast Center for surgical care, only steps away from the Doheny Eye Center. About Childrens Hospital Los Angeles: Founded in 1901, Childrens Hospital Los Angeles is one of the nation's leading children's hospitals and is acknowledged worldwide for its leadership in pediatric and adolescent health. Childrens Hospital Los Angeles is one of only seven children's hospitals in the nation - and the only children's hospital on the West Coast - ranked for two consecutive years in all 10 pediatric specialties in the U.S. News & World Report rankings and named to the magazine's 'Honor Roll' of children's hospitals. The Saban Research Institute at Childrens Hospital Los Angeles is among the largest and most productive pediatric research facilities in the United States, with 100 investigators at work on 186 laboratory studies, clinical trials and community-based research and health services. The Saban Research Institute is ranked eighth in National Institutes of Health funding among children's hospitals in the United States. Childrens Hospital Los Angeles is a premier teaching hospital and has been affiliated with the Keck School of Medicine of the University of Southern California since 1932.

Photos/Multimedia Gallery Available: http://www.businesswire.com/cgi-bin/mmg.cgi?eid=6501226&lang=en

Keywords: Blindness, ChildrenEs Hospital Los Angeles, Hospital, Pediatrics, Risk and Prevention.

суббота, 6 октября 2012 г.

New implantable lenses help correct vision.(Life - Health) - Albany Times Union (Albany, NY)

Byline: MARY BETH REGAN Baltimore Sun

When Cheryl Flood's husband had laser eye surgery to correct poor vision a few years ago, she was more than envious. 'I was downright resentful,' said the 40-year-old mother of two. 'He qualified for the surgery, but I didn't.'

Like many people, Flood wasn't a good candidate for conventional LASIK or other laser procedures because of corneal irregularities.

Still, she persevered in her quest for a glasses-free existence. She called her doctor, Sheri Rowen, every few months for nearly three years. She plunked money into her tax-free health care spending account in the hopes that a new technology would come along.

Eventually it did.

Last month, Flood was one of the first people in the United States to receive newly approved implantable lenses in a surgery by Rowen at Mercy Medical Center in Baltimore. The synthetic lens, widely used in Europe for more than a decade, was approved by the Food and Drug Administration in September. It will be marketed under the brand name Verisyse by Advanced Medical Optical Inc. of Santa Ana, Calif. A second lens by another company is expected on the market in the spring.

'These implantable lenses are the wave of the future,' Rowen said. 'They have the ability to correct vision with exact precision without altering the shape of the cornea.' And unlike laser procedures, which do alter the shape of the cornea, implantable lenses are permanent, although they can be removed if there are problems.

Flood arrived at Mercy Medical Center on a Wednesday morning with her sister, another LASIK patient whose vision was corrected several years ago. By 1 p.m., Flood had been lightly sedated and prepped for surgery on her left eye. In most eye surgeries, it's standard procedure to operate on only one eye at a time, in case there are complications. Her right eye was scheduled to be done at another time.

Rowen cut the bottom of Flood's cornea and suctioned up some blood. Then she slid surgical instruments beneath the cornea into the inner chamber of the eye.

Next, Rowen used tweezers to lift a synthetic lens from an operating table. The lens looked no different from any contact lens, except that it was slightly smaller. She then lifted the corneal tissue and placed the lens across the iris, over Flood's pupil.

In 10 minutes, the lens was in place. Rowen lifted muscle from the iris to anchor the lens. Then, using tweezers, she sewed the cornea back together with nylon thread thinner than a human hair.

The arrival of implantable lenses marks a departure from recent advances in corrective eye surgery. In the 1990s, doctors pioneered conventional LASIK treatments, which use lasers to reshape the cornea for sharper vision.

In recent years, computer and other technologies have refined the precision of laser surgery. In addition, doctors have begun using surface ablation procedures, such as LASEK and Epi-LASIK, which correct vision by reshaping the cornea without making any incisions in the eye.

But implantable lenses piggyback on an entirely different idea that has been around since the 1940s to correct cataracts, a clouding of the natural crystalline lens that causes blindness. Doctors have long treated cataracts by replacing the eye's natural lens with a synthetic lens.

This approach saves vision, but artificial lenses are not as pliable or responsive as the eye's natural lens.

Two decades ago, researchers in the Netherlands got the idea of placing an implantable lens into the eye to correct vision without removing the natural lens.

пятница, 5 октября 2012 г.

New Findings Reported from Manchester Royal Eye Hospital Describe Advances in Vision Research. - Health & Medicine Week

According to the authors of a study from Manchester, United Kingdom, 'Previous studies have demonstrated that the retention of information in short-term visual perceptual memory can be disrupted by the presentation of masking stimuli during interstimulus intervals (ISIs) in delayed discrimination tasks (S. Magnussen & W. W. Greenlee, 1999). We have exploited this effect in order to determine to what extent short-term perceptual memory is selective for stimulus color.'

'We employed a delayed hue discrimination paradigm to measure the fidelity with which color information was retained in short-term memory. The task required 5 color normal observers to discriminate between spatially non-overlapping colored reference and test stimuli that were temporally separated by an ISI of 5 s. The points of subjective equality (PSEs) on the resultant psychometric matching functions provided an index of performance. Measurements were made in the presence and absence of mask stimuli presented during the ISI, which varied in hue around the equiluminant plane in DKL color space. For all reference stimuli, we found a consistent mask-induced, hue-dependent shift in PSE compared to the 'no mask' conditions. These shifts were found to be tuned in color space, only occurring for a range of mask hues that fell within bandwidths of 29-37 deg. Outside this range, masking stimuli had little or no effect on measured PSEs. The results demonstrate that memory masking for color exhibits selectivity similar to that which has already been demonstrated for other visual attributes,' wrote V.A. Nemes and colleagues, Manchester Royal Eye Hospital (see also Vision Research).

The researchers concluded: 'The relatively narrow tuning of these interference effects suggests that short-term perceptual memory for color is based on higher order, non-linear color coding.'

Nemes and colleagues published their study in the Journal of Vision (The retention and disruption of color information in human short-term visual memory. Journal of Vision, 2012;12(1):400-413).

For more information, contact V.A. Nemes, Manchester Royal Eye Hospital, Vis Sci Center, Manchester M13 9WH, Lancs, United Kingdom.

Publisher contact information for the Journal of Vision is: Assoc Research Vision Ophthalmology Inc, 12300 Twinbrook Parkway, Rockville, MD 20852-1606, USA.

Keywords: City:Manchester, Country:United Kingdom, Region:Europe, Vision Research

четверг, 4 октября 2012 г.

Smith-Kettlewell Eye Research Institute describes research in vision research. - Health & Medicine Week

Data detailed in 'Measurements of long-range suppression in human opponent S-cone and achromatic luminance channels' have been presented. According to recent research published in the Journal of Vision, 'Cortical responses to spatially discrete patches of achromatic luminance contrast can be altered by the presence of high-contrast, spatially remote 'surrounds' and this achromatic 'surround suppression' has been the subject of much recent research. However, the nature of long-range contrast normalization in chromatic signals has been less studied.'

'Here we use a combination of neuroimaging data from source-imaged EEG and two different psychophysical measures of surround suppression to study contrast normalization in stimuli containing achromatic luminance and S-cone-isolating contrast. In an appearance matching task, we find strong within-channel but little between-channel suppression. However, using a contrast increment detection task, we do find evidence for weak but significant between-channel effects. Our neural measurements agree with the appearance matching data, showing significant within-channel suppression and no significant interactions between signals initiated in different pre-cortical pathways. We hypothesize that appearance judgments and V1 population responses are dominated by neurons with chromatically matched classical and extra-classical surrounds while contrast increment detection tasks rely on a subpopulation of neurons that have extra-classical surrounds sensitive to both chromatic and achromatic contrasts,' wrote B. Xiao and colleagues, Smith-Kettlewell Eye Research Institute (see also Vision Research).

The researchers concluded: 'Our psychophysical and source-imaged EEG results are consistent with a hypothesis based on natural scene statistics that long-range contrast normalization in early visual system is largely driven by signals within the same chromatic channel.'

Xiao and colleagues published their study in the Journal of Vision (Measurements of long-range suppression in human opponent S-cone and achromatic luminance channels. Journal of Vision, 2010;10(13):10).

For additional information, contact B. Xiao, Smith-Kettlewell Eye Research Institute, Brain Imaging Center, CA USA.

The publisher's contact information for the Journal of Vision is: Association Research Vision Ophthalmology Inc., 12300 Twinbrook Parkway, Rockville, MD 20852-1606, USA.

Keywords: State:CA, Country:United States, Vision Research.

среда, 3 октября 2012 г.

Business with a vision. (Health Care News). - Hawaii Business

Chapman, Tom

Dwayne Myles, a Honolulu-based flight attendant for United Airlines, claims that on May 8, 2001. When he walked into the Laser Eye Center of Hawaii, he was as good as blind without his glasses. Badly nearsighted since the age of 10, he had 20/400 vision in each eye. An hour later, when he left the center after undergoing Laser-Assisted in-Situ Keratomileusis, a type of surgery better known as LASIK, his vision was corrected to a perfect 20/20 in one eye and 20/25 in the other. Says Myles: 'I laughed. I cried. When I went home I could see the details of a butterfly in my yard for the first time. And since the operation. I've forgotten that I ever had to wear glasses.'

It appears to be a simple procedure, and everybody talks about it that way. LASIK, a specialized blade called a microkeratome, slices a flap of your cornea that surgeons claim is thinner than a grape skin. The flap is lifted and peeled back form the cornea with a tiny instrument. A clicking sound is heard as the surgeon applies a beam of cool ultraviolet light in pulses from a laser to vaporize a microscopic amount of issue from the cornea, in effect, reshaping it. The flap is than returned to its original position, The relatively painless surgery lasts only seconds to up to 20 minutes for two eyes. All being well, it has a short recovery period; you're back to work in a day.

In 2000, an estimated 4,000 persons in Hawaii elected to have refractive corneal surgery to correct astigmatism or nearsightedeness, or to climinate the wearing of contact lenses or eyeglasses, and leading practitioners believe that only 10 percent of the market here has been penetrated, making this a significant medical growth industry.

Yet, with all the success that the procedure has had (estimates are that 1.5 million Americans underwent LASIK surgery in 2001), prospective patients are urged to proceed with care and not to trivialize it. Side effects and complications can occur with both LASIK and PRK, an older procedure in which the outer protective layer of the corneal is directly sculpted and removed by the excimer laser.

'With either procedure there are essential things you must consider,' says Dr. Dennis M. Kuwabara, president of the Laser Eye Center of Hawaii. 'The qualifications of the surgeon, who should have done at least a thousand procedures; the quality of the center, which must have state-of-the-art equipment; and proper screening and preparation.'

In this complex medical field, a completely new subspecialty within the science of ophthalmology, many discount laser eye centers opened nationwide to grand fanfare in the '90s, often competing on prices and false promises of perfection, then closed with a thud, contributing to vast misconceptions and considerable controversy within the profession. But Hawaii is still an uncluttered field, with only seven major centers now performing the procedure, all boasting high standards of care, technology and, apparently, strong codes of ethics. Three early Hawaii entrants -- True Vision, St. Francis Hospital and Lasix Vision Corp. -- left the field not long after they entered it ('One realized the learning curve was a little steeper than they had anticipated, the other two were only interested in the bottom line,' according to one eye surgeon). Six other facilities remain: Laser Eye Center of Hawaii (formerly the Laser Eye Institute of Hawaii), Eyesight Hawaii, Pan-Pacific, Hawaiian Eye, Queen's Hospital, Kaiser Perma nente and Aloha Laser Vision.

Clearly, the cost for laser eye surgery shouldn't be your prime reason for evaluating a doctor or a center. (Nationwide costs for LASIX surgery at quality centers is about $1800-2400 per eye.)

'When the discount centers came into being, people thought the procedure was a matter of someone simply pushing a button,' says Dr. John Olkowski, chief surgeon at Eyesight Hawaii, who has been practicing corneal and refractive surgery in Hawaii for over 10 years and who last year performed LASIK surgery on his mother-in-law live on the Fox 2 morning news.

Olkowski, who has performed more than 4,000 operations, pointed to a study conducted by Harvard Medical Center's Ophthalmology Department, which demonstrated that a surgeon's complication rate for his first 600 eyes was about 3 percent, a figure which then diminishes to .01 percent for future procedures.

The trouble is that, because they often operate on normal eyes that see 20/20 with correction, laser surgeons acknowledge that controversy will continue to exist within their specialty. 'The actual time the laser is functioning is usually less than one minute, but within that one minute a lot of things can go wrong,' said Dr. Tyrie Lee Jenkins, medical director and ophthalmic surgeon at Laser Eye Center of Hawaii, who performed Hawaii's first LAS 1K surgery (and operated on Dwayne Miles).

вторник, 2 октября 2012 г.

Champion of Blinded Soldiers, Congressman Murtha Named Man of Vision by Schepens Eye Research Institute. - AScribe Medicine News Service

Byline: Schepens Eye Research Institute

BOSTON, Dec. 17 (AScribe Newswire) -- Schepens Eye Research Institute has named Congressman John P. Murtha, Chairman of the House Appropriations Subcommittee on Defense, this year's Man of Vision for his advocacy on behalf of veterans blinded by war and for research to restore their vision.

Each year the Institute gives the Man of Vision Award, its highest honor, to an individual who has made lasting contributions to vision research and the awareness of the challenges of vision loss. Among previous awardees have been jazz legend Ella Fitzgerald, journalist and Time Magazine's managing editor Henry Grunwald, and Boston philanthropist Dick Harte.

For more than 30 years, Murtha of Johnstown, Pennsylvania, has pushed for medical research partnerships that target the specific needs of war fighters and veterans. Most recently, his initiatives have helped the Department of Defense respond proactively to the increasing number of eye injuries suffered by American soldiers in Afghanistan and Iraq.

In accepting the award from Schepens officials last week, Murtha said, 'We owe our troops more than just a debt of gratitude. We owe them the best care this country has to offer, today and in the future. Investing in vision research is an important part of making sure we can offer the care they need.' Massachusetts Congressman Jim McGovern, an avid Schepens supporter, was on hand for the award presentation.

Massachusetts Congressmen Mike Capuano and Stephen Lynch, who have long been champions of vision research at Schepens, also voiced their support for this recognition of Murtha's advocacy. 'Congressman Murtha's commitment to vision research is critical to addressing the health needs of the men and women who have given so much for this country,' said Capuano. 'Without question, Mr. Murtha's efforts will not only benefit our returning veterans but will also relieve the suffering of millions of people who are affected by serious eye injuries and diseases throughout the world,' added Lynch.

Experts estimate that between 16 and 20 percent of returning soldiers have eye injuries, and many of those with traumatic brain injuries are also experiencing vision complications. Much higher than in previous wars, the incidence of eye injuries has been the result of the wide use of Improvised Explosive Devices and advanced armor technology that saves lives by shielding the body's core, but does little to protect the face and extremities.

Well-respected for his firsthand knowledge of military and defense issues, Murtha has been a trusted adviser to presidents of both political parties. In response to the flood of military eye injuries seen at Walter Reed Army Medical Center, Murtha initiated a research partnership between the Department of Defense and Schepens Eye Research Institute, the country's largest eye research institute. The success of this partnership -- which stimulated study of issues ranging from nerve regeneration to enhanced heads-up displays to warn soldiers in the battlefield -- has encouraged DoD to build a vision research program, which now includes additional partners from around the country.

'With Congressman Murtha's encouragement and leadership, we have been able to show that nerve regeneration is, in fact, possible,' notes Dr. Michael S. Gilmore, President and CEO of Schepens and Professor of Ophthalmology at Harvard Medical School. 'This work, which has been funded through his efforts, is exciting scientifically, and opens the way for new treatments not only for optic nerves and retinas damaged in combat, but also for veterans who have suffered spinal and brain injuries on the battlefield.'

- - - -

CONTACT: Patti Jacobs, Schepens Eye Research Institute, (000)-000-0000, pjacobs12@comcast.net

For additional information on Schepens Eye Research Institute contact Patti Jacobs or visit http://www.schepens.harvard.edu .

понедельник, 1 октября 2012 г.

Researchers at Prasad Eye Institute target public health.(Report) - China Weekly News

A new study, 'An estimate of patient costs and benefits of the new primary eye care model utilization through vision centers in andhra pradesh, India,' is now available. According to a study from Hyderabad, India, 'Little or no work has been carried out in developing countries on costs to patients and patient benefits in accessing primary eye care services. The purpose of this study was to assess the indirect, direct, and overall costs of patients accessing vision care at vision center services (New Primary Eyecare Approach) as compared with the nearest private clinic.'

'The authors used a standardized questionnaire and a paired sample t test to check the significance of difference of costs. They considered a P value of <.05 as significant in this study,' wrote V. Kovai and colleagues, Prasad Eye Institute.

The researchers concluded: 'The total costs were significantly lower for patients who accessed the vision centers compared with the costs these patients may have incurred if they had sought services from the nearest town-based clinic (mean in Indian rupees [INR] of 178.4 [+ or -] 48.3, standard error of the mean=4.2, and INR 366.2 [+ or -] 48.2, standard error of the mean=4.2, respectively, t test P value <.001). vision centers, besides providing quality eye care services, offer substantial cost savings to rural populations compared with town-based optical clinics.'

Kovai and colleagues published the results of their research in Asia-pacific Journal of Public Health (An estimate of patient costs and benefits of the new primary eye care model utilization through vision centers in andhra pradesh, India. Asia-pacific Journal of Public Health, 2010;22(4):426-35).

For additional information, contact V. Kovai, International Centre for Advancement of Rural Eye Care, LV Prasad Eye Institute, Hyderabad, India.

The publisher of the Asia-pacific Journal of Public Health can be contacted at: SAGE Publications, USA , 2455 Teller Road, Thousand Oaks, CA 91320, USA.

Keywords: City:Hyderabad, Country:India, Asia, China, India, Public Health.

воскресенье, 30 сентября 2012 г.

Menino vows to keep up changes Eyes schools, health, housing, government - The Boston Globe (Boston, MA)

Fresh from his free ride to a second term Tuesday, Mayor ThomasM. Menino yesterday pledged to do a better job organizing his visionof the city's future, identifying several areas that need carefulattention to make Boston a No. 1 destination for businesses,visitors, and residents.

Menino also promised shake-ups in the structure of citygovernment, hinting that he might try to improve the delivery of cityservices with innovations being used in other cities such asPhiladelphia and Indianapolis. A two-day retreat with top officialsis planned for next week.

суббота, 29 сентября 2012 г.

WHO Reports Lists Risk Factors For Progression In Eye Disease.(World Health Organization ) - Angiogenesis Weekly

2001 OCT 5 - (NewsRx.com & NewsRx.net) --

by Sonia Nichols, senior medical writer - Age, body mass index (BMI), and glucose control are just some of the risk factors for diabetic retinopathy progression and proliferation in types 1 and 2 diabetes patients, according to World Health Organization (WHO) collaborators.

Diabetic retinopathy, characterized by hemorrhage, microaneurysms, lesion formation, and sometimes new blood vessel overgrowth (proliferative retinopathy) in the retina, can lead to total vision loss in diabetes patients. A follow-up study of almost 3,000 patients with types 1 or 2 diabetes at 10 WHO centers suggests several factors contribute to progressive eye disease in patients with diabetic retinopathy.

Originally, investigators enrolled over 4,600 patients with diabetes in the study. More than 500 of those patients were lost to follow-up due to death, according to H. Keen and colleagues, Guy's Hospital, London, U.K. During follow-up 47.7% of patients who did not have retinopathy at study enrollment developed retinopathy, and 9.7% developed proliferative retinopathy, according to Keen and colleagues.

'Incident retinopathy appeared earlier in the known course of diabetes but incidence rates rose more slowly with duration in patients with type 2 (non-insulin-dependent) diabetes mellitus than in those with type 1 (insulin-dependent) diabetes mellitus,' reported Keen and coworkers.

After pooling the data from the several study centers, researchers identified several factors that increased the odds of incident retinopathy, which they listed as 'age, diabetes duration, systolic pressure, plasma cholesterol, BMI, insulin treatment and proteinuria, and fasting glycemia.'

For those with proliferative diabetic retinopathy, 'age, diabetes duration, insulin treatment, cholesterol, proteinuria, and fasting glycemia' were high-risk factors ('The appearance of retinopathy and progression to proliferative retinopathy: The WHO multinational study of vascular disease in diabetes,' Diabetologia, 2001;44(14):S22-S30).

Although the prevalence of incident retinopathy and proliferative retinopathy varied from center to center, implying observer differences, baseline risk factors for retinopathy remained important throughout the entire study group.

'Improved detection and control of these risk factors should reduce the impact of diabetic retinopathy and its consequences,' Keen and coauthors. said.

The corresponding author for this study is H. Keen, Guy's Hospital, London, UK.

A search at www.NewsRx.net using the search term 'diabetic retinopathy' yielded over 47 articles in 11 specialized reports.

Key points reported in this study include:

* A major WHO study identified incident retinopathy in almost 50% of type 1 and 2 diabetic patients followed for an average of 8.4 years

* Proliferative retinopathy was identified in almost 10% of diabetes patients

* Several controllable factors increase the risk for diabetic retinopathy in patients with types 1 and 2 diabetes

пятница, 28 сентября 2012 г.

WHO Reports Lists Risk Factors For Progression In Eye Disease.(World Health Organization)(Brief Article) - Diabetes Week

2001 OCT 1 - (NewsRx.com & NewsRx.net) --

by Sonia Nichols, senior medical writer - Age, body mass index (BMI), and glucose control are just some of the risk factors for diabetic retinopathy progression and proliferation in types 1 and 2 diabetes patients, according to World Health Organization (WHO) collaborators.

Diabetic retinopathy, characterized by hemorrhage, microaneurysms, lesion formation, and sometimes new blood vessel overgrowth (proliferative retinopathy) in the retina, can lead to total vision loss in diabetes patients. A follow-up study of almost 3,000 patients with types 1 or 2 diabetes at 10 WHO centers suggests several factors contribute to progressive eye disease in patients with diabetic retinopathy.

Originally, investigators enrolled over 4,600 patients with diabetes in the study. More than 500 of those patients were lost to follow-up due to death, according to H. Keen and colleagues, Guy's Hospital, London, U.K. During follow-up 47.7% of patients who did not have retinopathy at study enrollment developed retinopathy, and 9.7% developed proliferative retinopathy, according to Keen and colleagues.

'Incident retinopathy appeared earlier in the known course of diabetes but incidence rates rose more slowly with duration in patients with type 2 (non-insulin-dependent) diabetes mellitus than in those with type 1 (insulin-dependent) diabetes mellitus,' reported Keen and coworkers.

After pooling the data from the several study centers, researchers identified several factors that increased the odds of incident retinopathy, which they listed as 'age, diabetes duration, systolic pressure, plasma cholesterol, BMI, insulin treatment and proteinuria, and fasting glycemia.'

For those with proliferative diabetic retinopathy, 'age, diabetes duration, insulin treatment, cholesterol, proteinuria, and fasting glycemia' were high-risk factors ('The appearance of retinopathy and progression to proliferative retinopathy: The WHO multinational study of vascular disease in diabetes,' Diabetologia, 2001;44(14):S22-S30).

Although the prevalence of incident retinopathy and proliferative retinopathy varied from center to center, implying observer differences, baseline risk factors for retinopathy remained important throughout the entire study group.

'Improved detection and control of these risk factors should reduce the impact of diabetic retinopathy and its consequences,' Keen and coauthors. said.

The corresponding author for this study is H. Keen, Guy's Hospital, London, UK.

A search at www.NewsRx.net using the search term 'diabetic retinopathy' yielded over 47 articles in 11 specialized reports.

Key points reported in this study include:

* A major WHO study identified incident retinopathy in almost 50% of type 1 and 2 diabetic patients followed for an average of 8.4 years

* Proliferative retinopathy was identified in almost 10% of diabetes patients

* Several controllable factors increase the risk for diabetic retinopathy in patients with types 1 and 2 diabetes

четверг, 27 сентября 2012 г.

AAO, New York to gather vision health data - Ophthalmology Times

FROM STAFF REPORTS

Washington-The American Academy of Ophthalmology (AAO) has partnered with the New York State Department of Health to include new questions about visual impairment and access to eye care in its annual 2006 Behavioral Risk Factor Surveillance System (BRFSS).

The BRFSS, a state-based survey program, was developed by the Centers for Disease Control and Prevention to monitor state-level prevalence of major behavioral risks associated with morbidity and mortality among adults.

среда, 26 сентября 2012 г.

JOE'S VISION OPENED EYES - The Record (Bergen County, NJ)

BILL PENNINGTON
The Record (Bergen County, NJ)
09-29-1996
JOE'S VISION OPENED EYES
By BILL PENNINGTON
Date: 09-29-1996, Sunday
Section: SPORTS
Edition: All Editions -- Sunday
Biographical: JOE TORRE

We had a good laugh, most of us did, on Nov. 2, 1995.

Joe Torre was named the new Yankees manager, and he said things
like: 'I'm coming into this with my eyes wide open.'

Oh, how naive. How sad.

The poor man doesn't have a clue. George will chew him up, gnaw on
him until there's nothing left. At the luncheon announcing Joe Torre's
hiring, one question circulated the room: How long do you give him?

No one gave Joe Torre a chance past July. As it happened, George
Steinbrenner did not even wait that long, surreptitiously trying to
convince Buck Showalter to return to the Yankees in a top secret meeting
just days after Torre was introduced as the new manager.

How sad. Poor Joe.

Joe Torre, cigar in mouth, can laugh at all of us now. It is we who
misread this man, who underestimated his ability to adapt, to endure. It
has been 11 months in the Yankees crucible. They have been some of the
longest days of his life, and they have been some of the best.

Steinbrenner may yet fire him in two weeks, two months, or two
years, but the 1996 Yankees season is one tribute to Joe Torre's
unwavering poise. He is a symbol of this long season, the placid, serene
force moving across the days and weeks. He is the duck cruising across
the pond -- propelled, it seems, without effort, all the while churning
with energy beneath the surface.

Because if you think Torre has not longed for this success, you are
wrong. A couple of weeks ago, talking about how he had never played or
managed in the World Series despite 37 years in Major League Baseball,
56-year-old Joe Torre said he would keep coming back to the game 'until
I get it right.'

And this past week, on the day after the Yankees had clinched the
American League East, Torre allowed that he woke up a different man.

'It was the first day all year that I got out of bed without a
concern, without a question on my mind, without thinking that there were
decisions to make, things to settle or figure out,' he said. 'It was an
unbelievable relief.'

So you know he has felt the pressures even if he has masked them in
cigar smoke. In a year when he has had to endure the death of one
brother and the ongoing health problems of another, Torre has also
played shepherd to a diverse roster of young, old, multi-experienced,
and multilingual players -- with all the baseball world, and one
omnipresent owner, watching.

He has had players handed to him he did not seek and lost players
he never wanted to do without. He has observed the media circus from the
center ring, showing the ability to be pleasant and honest without
causing a stir. Best of all, he can, and does, sit in a roomful of
reporters completely silent when silence is the best option.

'He feels things a lot more than he shows,' Yankees third base
coach Willie Randolph said last week. 'He's very emotional. When you sit
next to him on the bench, he jumps and flinches, but then he catches
himself and holds it in.

'I've played for or been around a lot of managers, from Billy
[Martin] and Lou [Piniella] to Dick Howser and Tommy Lasorda to Tony La
Russa, and Joe is remarkable for how steady he can be. I admire him for
how he could keep his personality so stable throughout the whole
season.'

And since he is so undemonstrative in public, there are many things
about him that are little known. And herewith, a short sampler of the
unseen Joe Torre:

Joe Torre, the sentimentalist:

When the Yankees were one inning from clinching their division
title, Torre carefully selected the pitcher he wanted on the mound for
the final out.

'It was very important that it be someone who has gone through the
whole struggle, since spring training,' Torre said. 'I wanted someone
who's been with us the whole way.' He found reliever Jeff Nelson, a
pitcher who bedeviled Torre with his inconsistency through the summer,
but someone Torre continues to embrace as integral to the fold.

Joe Torre, the players' manager:

'It's not enough to look at a guy's stats and say he's not doing
his job,' said Torre. 'I hit .360 in the majors one season and .240 in
another season. And I know I was trying just as hard both times.'

Joe Torre, the humorist:

Asked if he expected to testify at the late October hearing
concerning the validity of the Graeme Lloyd trade, Torre answered: 'I'm
glad you reminded me of that. I'll have my boarding pass to somewhere by
then.'

Joe Torre, the loyal friend:

Asked if he would be upset if embattled general manager Bob Watson
was fired, as most expect, Torre said: 'Bob brought me here. We're a
team. You'd have a tough time telling me he didn't do a good job.'

And finally, Joe Torre, the compassionate:

Reading the congratulatory fax sent to him by Don Mattingly, Torre
said: 'You know it has to be tugging at him to have only gotten a taste
of it last year. I wish he were here.'

It is just about 11 months since Torre was handed the Yankees'
helm, and given the state of the team then, it is just about a miracle
that he is still here, still in the job. You can say that the Yankees
had loads of talent, but it is never the pieces alone that make a unit
powerful. It is how they are used. When the pieces are people -- or to
increase the challenge, multimillionaires pampered since high school --
managing a baseball team is indeed a craft not to be underestimated.

And consider that Torre is the 13th man across 23 seasons to manage
Steinbrenner's Yankees. He is just the fourth to lead George's talented
charges to a division title.

The Yankees are in the playoffs again and Joe Torre is the manager
of this successful team and its happy legion of fans. Those of us in
that room on Nov. 2, 1995, underestimated the resolve, skill, and
restraint of this man.

He said he came into the job with his 'eyes wide open,' and we
laughed. He spent the next 11 months opening our eyes to the Joe Torre
we had never seen.

Keywords: BASEBALL. PROFESSIONAL. COACH

Copyright 1996 Bergen Record Corp. All rights reserved.

Vision for eye care - The Sun - Naperville (IL)

With the help of some insurance carriers, local independent eye-care professionals seem to be bucking one trend — consolidation of small enterprises into large conglomerates.

Despite corporate stores that claim to offer fast service and extra product, the independent optometrist continues to thrive — especially those who are well past their medical school years.

"It would certainly be daunting of a young graduate to open his own practice right out of school given the debt many have and, more importantly, having no knowledge of how to run a business," said Dr. Dennis DeLee, 63, who works in Chicago in a practice he bought 11 years ago. "To me, the independents are still very successful and offer things the corporate sector can't."

Two Naperville doctors who are married to each other work in DeLee's office.

DeLee cites advantages that include personalized service, state-of-the-art technology, and medically related services that often characterize the independent service provider — services that he says don't necessarily have to cost more than patients can afford.

Dr. Richard Butz, 54, who operates the Professional Eye Center, 1112 S. Washington St., in Naperville, agrees that diagnostic patient-care services are often superior when using an independent eye care practitioner, and that many insurance plans make service costs "even cheaper than the warehouse doctors charge."

"I bought my own business 21 years ago, although I did work in the corporate setting before that, and I really enjoy the element of having more control," Butz said. "I can make decisions on equipment and my schedule, and I can delve into patient care more deeply.

"I can remember in the corporate setting telling management that I wanted this particular contact lens to treat a patient or some different product, and they'd just say 'no' and not do it."

Funneling clients

Insurance providers like VSP have joined in the effort to help independents be successful. Cheryl Johnson, vice president of provider services, said her company focuses on private practitioners.

"VSP Vision Care is the largest not-for-profit vision benefits company in the United States with 56 million members and a network of 27,000 independent eye care doctors, including 18 doctors in Naperville," Johnson said. "VSP is committed to the success and growth of private practice. Our focus is on promoting the high-quality care our doctors deliver and continuing to increase the number of patients we send to them."

Ray Kinney of Naperville's Minuteman Press said his employees receive independent insurance benefits and that many, including Kinney, believe in the service and reputation of independent doctors.

"I'm a big proponent of service, and I've been going to the same doctor for years," Kinney said. "I feel it's important you have someone who knows your history, and while I wouldn't rule out getting a pair of sunglasses or an extra pair of contacts from a franchise eye care service, I wouldn't ever replace my own private practitioner."

Negotiating rates

Insurance brokers like Naperville's Bill Hayes who works for the Esser Hayes Insurance Group suggest that costs through an insurance program like VSP often can be more reasonable "based on negotiated better rates."

"Some practitioners may charge $100 for an eye exam, and VSP might have negotiated with some doctor or group practice to lower that to $50," Hayes said. "The premiums paid each month by a company to the insurance carrier can more than make up for the money lost in lowered fees."

Hayes' colleague Tom Pruett, who serves as the vice president of employee benefits says that while only five percent of those with a group health plan purchase separate vision insurance, there are others with free programs included.

"Some of the group health insurance companies offer a free vision discount program for eye exams, frames and lenses and contacts, so a majority of our groups have a no-cost vision discount program although they are not as comprehensive," Pruett said.

Dr. Allen Smith, 49, of English Rows Eye Care in Naperville, just opened his own practice 18 months ago and believes managed health care plans like VSP have been essential in helping his practice grow.

"Having an insurance plan like this allows patients to have a place to go and not pay more than they would at a big box retailer," Smith said. "Having a managed care plan is essential, but for me, it's also about living and working in Naperville.

"I've practiced here in the city the past 20 years, and I moved here within the last 12. The quality of people here is what attracts others to my practice, which is essential as well."

вторник, 25 сентября 2012 г.

LASER OPERATION ABLE TO RESHAPE EYE SURFACE TO CORRECT VISION - Post-Tribune (IN)

THIS ELECTRONIC VERSION MAY DIFFER SLIGHTLY FROM THE PRINTED VERSION.

Imagine a world where eyeglasses are museum pieces and contact lenses are obsolete. Such a time may not be far off. Government-approved tests of a new operation, in which a laser beam is used to reshape the surface of the eye to correct vision permanently, have been very encouraging, a researcher reported on Wednesday.

So far, 75 patients have undergone the surgery, said Dr. Keith P. Thompson, an assistant professor of Ophthalmology at the Emory University School of Medicine in Atlanta, and a scientist at the Yerkes Regional Primate Research Center.

He said half the patients achieved vision of 20/20 or better, considered perfect. And nine out of 10 improved to 20/40, good enough to pass a driver's test without glasses.

Thompson reported the results of the study to the 10th Annual Science Reporters Conference, sponsored by the American Medical Association.

The U.S. Food and Drug Administration wants to see follow-up reports on 500 patients two years after their surgery before approving the procedure for public use. A new phase of the study, designed to meet that requirement, is now beginning at Emory and various sites across the country, and an FDA ruling may come in three years.

Thompson predicted the surgery might be available to the public by the end of the decade.

Other kinds of operations to correct vision have been developed and used over the last 10 years.

But they involve incisions in the cornea, the transparent membrane that covers the eye. And because the cornea does not heal as well as other tissues, it is left structurally weakened, Thompson said.

By contrast, the new procedure consists of using a new, ultraviolet laser to sculpt the surface of the cornea. The cornea is about as thick as a credit card, and only a few thousandths of an inch are etched away, reshaping the surface to put the eye back in focus.

The operation takes about 15 seconds, and the eye heals within six weeks, Thompson said.

No health risks have been associated with the surgery, he said. Some haze develops in the cornea, but it disappears in three to six months, he said. Some patients see halos when they look at lights, but that, too, seems to resolve itself over time.

Age does not appear to be a factor in the success of the surgery, he said.

Many of the patients in the study, after waiting the six months required by the Food and Drug Administration, have chosen to have their second eye operated on, he added.

So far, the procedure is being used only for nearsightedness. About one of every four people in the United States is nearsighted.

The operation costs $1,500 per eye because the new lasers cost about $400,000 each, and the number of patients is so small, Thompson said. But he said he expected the cost to drop significantly once the operation is available to the public.

Thompson said he did not know whether the operation could be repeated to adjust for continually deteriorating vision. But he said most people's eyesight remains relatively stable, with only slight variations over time.

понедельник, 24 сентября 2012 г.

Rolling the dice on RK: controversy surrounds radial keratotomy, but thousands of Arkansans take the risk. (eye surgery for nearsightedness) (Health Care Update) - Arkansas Business

THE THOUGHT OF CUTTING into a human eye makes anyone but an ophthalmologist cringe. It's a procedure traditionally reserved for ocular disease and trauma -- conditions that leave no choice but surgery. In the absence of infirmity, most people would prefer to keep all sharp objects away from their peepers, thank you very much.

So why is it that thousands of Arkansans have paid $1,000 an eyeball to subject their corneas to radial keratotomy, a relatively new and somewhat risky surgery to correct nearsightedness?

The answer, of course, is freedom.

Freedom from heavy, awkward glasses that rub their noses, fall off during basketball games and fog up in winter. Freedom from annoying, shifting, abrasive contact lenses, which can feel like breakfast cereal in the eyes and occasionally bring grown-ups to their knees when they slide into a tear duct.

The trouble is, RK guarantees no such freedom.

'The main problem is the unpredictability of it,' says Dr. Michael Roberson of the Little Rock Eye Clinic, an ophthalmologist who frequently performs the procedure.

'Nobody has ever obtained 100 percent success with radial keratotomy. You are doing a statistical operation.'

Surgery by the numbers, so to speak.

The root cause of the trouble is nearsightedness. Also called myopia, it's a condition in which incoming light rays are excessively bent or refracted by a misshapen cornea, causing the rays to focus in front of the retina rather than directly on it.

Fully 25 percent of the population in Western countries suffers from this condition. Most cope by wearing glasses or contacts.

For those who shun tradition, there is radial keratotomy.

The RK surgeon makes 4-16 radial incisions in the cornea with a diamond blade, with each cut emanating from the rim of the eye to the center without extending over the pupil.

The incisions cause the edges of the cornea to spread and the center to flatten. The flattened cornea moves the focus of incoming light backward -- to the surface of the retina, it is hoped -- theoretically producing focused vision.

But it is rarely that simple.

Statistics Bare Studying

Two studies conducted in the 1980s found that only 76 percent of the eyes that underwent RK surgery achieved visual acuity of 20/40 or better, the level of vision needed to pass a driver's license test in Arkansas.

Patients who have lived with very poor vision might consider 20/40 a miracle. But fully 24 percent of the patients studied didn't fare so well, meaning they would once again be required to wear glasses.

RK patients are sometimes left with vision that fluctuates under different conditions, requiring more than one lens prescription.

For a few weeks after the procedure almost all patients experience a 'starburst' or 'halo effect' when they go from darkness to light. Sometimes the effect can linger.

The operation sometimes over-corrects an eye, sending it into farsightedness, or presbyopia.

And, in rare cases, the surgery can be downright dangerous.

'It is not universally safe,' says Dr. Hamp Roy of Little Rock. 'There have been some eyes that have been lost -- perforated with the diamond knife and infected.'

Roy performs RK surgery, mostly for elderly people who have had cataracts removed and are more nearsighted than they would like to be.

As a result of these problems, many ophthalmologists are careful about whom they approve for the procedure.

The candidates must not be too nearsighted, lest they prove incurable, and their vision can't be better than 20/40, in the event RK actually makes it worse. The successful candidate also must have a realistic attitude. Anyone expecting perfect vision is usually pointed to the eyeglasses department.

The RK procedure begins with a dosage of Valium and anesthetic drops for the eye. A special device restrains the eyelids from blinking, and another device marks black lines on the cornea where the cuts will be made.

The entire surgery can last as little as 10 minutes.

To date, health insurance plans generally have snubbed the surgery, considering it unproven and unnecessary.

Why Take the Chance?

The rap on RK is that it is a procedure done on healthy eyes -- an elective procedure that can't possibly improve vision over the glasses or contacts already available. If patients choose RK surgery, they are taking a chance, however small.

But to some, the chance is definitely worthwhile.

Wendy Bush, a 31-year-old certified public accountant from Sherwood, underwent RK last year.

'I'd do it again in a heartbeat,' she says, recalling how her extreme myopia was transformed to 20/20 vision in one eye and 20/25 in the other. She had worn glasses since age 5.

Bush had to undergo 'enhancements,' however, meaning follow-up visits to improve the results of the original surgery. The first time, in March, her vision was corrected to only 20/40. In August, Dr. R.E Hardberger of Little Rock retraced the incisions, making them slightly deeper.

Fred Vanpool is not so sure of his results.

Vanpool, 30, a Fayetteville computer programmer for Tyson Foods Inc., had the surgery two weeks ago at the clinic of Dr. J.E. McDonald II in Fayetteville.

'One of my eyes sees a little better than the other and it throws me off,' he says. 'I wouldn't have had it done if I thought I would still need to wear glasses.' The effect, he has been told, may be temporary.

There are alternatives to RK.

Through a technique called orthokerateology, optometrists can fit myopic patients with special contact lenses that actually change the shape of the cornea over time.

Dr. Jerry Shue, an optometrist in North Little Rock, says he also has had success with young, highly motivated patients in using biofeedback therapy to help them relax the muscles that focus the eye to the point that near-20/20 vision can be obtained.

This method only works for a limited number of patients, however. Shue says it is particularly good for pilots, who must maintain near-perfect uncorrected vision.

There are a few RK giants in the state -- clinics that advertise heavily and can boast of thousands of procedures. Chief among them are Hardberger-Capps Eye Center in Little Rock, Dr. James R. McNair in Little Rock and Newport, Eye Care-Surgical Associates in North Little Rock and the McFarland Eye Surgery Center in Pine Bluff.

Some of the big-time RK clinics offer free seminars and videotapes for those considering the surgery and vans to ferry the patients back and forth from the clinics.

Dr. Frank Teague of Hot Springs is hoping to join that company. Teague began performing RK in June, but already he is flooding the evening airways with testimonial ads and offering to send videotapes to any tentative viewers.

'We charge $850 an eye,' Teague says. 'I think some people have lowered their prices to be like us.'

But, in all his enthusiasm, Teague has not forgotten the No. 1 rule:

воскресенье, 23 сентября 2012 г.

At first sight: early screening can save more than your child's vision.(health report) - Sarasota Magazine

according to researchers at Miami's Florida International University, one in every 677 children in America is afflicted with some sort of treatable eye disease, including conditions that can cause blindness.

Strabismus, or 'crossed eyes,' and amblyopia, or 'lazy eye,' both affect as many as 5 percent of all preschool children. Infantile glaucoma occurs in one out of every 10,000 births, and cataracts account for 16 percent of all cases of legal blindness in children under the age of five. Yet only 14 percent of those below the age of six are likely to have had an eye examination, according to the American Optometric Association (AOA). And even though one in four school-age children has a vision-related problem, Kentucky is still the only state that requires professional eye exams for all pre-kindergarten students.

'An infant's eyes grow continuously after about seven weeks in the womb,' says Dr. Charles Doering, a vitreoretinal surgeon at Sarasota's Center for Sight. And a lot can go wrong in those critical days before birth.

One of the most ominous developments is retinoblastoma, a cancer caused by fetal retinal cells, called retinoblasts, that grow out of control, forming a tumor that fills much of the eye. About 40 percent of the time, this abnormality is genetic. Scientists have traced it to a mutation in a tumor suppressor gene known as Rb or RB1. About 90 percent of the children who inherit an abnormal Rb gene from a parent develop retinoblastoma in one or both eyes.

'The important thing about retinoblastoma is that children who develop it are at risk for developing secondary cancers of the bone and skin,' says Doering. If cells break away from the original tumor to other parts of the eye, they can create pressure inside the eye that leads to glaucoma. They can also spread to the optic nerve and brain, the lymph nodes, then to internal organs and the bones.

[ILLUSTRATION OMITTED]

Retinoblastoma is easy to spot by looking into a child's dilated eyes with a bright penlight or an ophthalmoscope. While a normal retina reflects back red, a retinoblastoma tumor will create a white reflection, a condition called leukocoria. The first clue for many parents is a child's photograph where the flash produces one red eye and one white eye.

Unfortunately, by the time a tumor reaches this stage, it may be too late to save the eye. Between 86 to 90 percent of children who are diagnosed with retinoblastoma because of leukocoria survive, but a Cornell University study of nearly 2,000 retinoblastoma patients who had been treated at the hospital found that saving a child's vision requires early detection. Patients with a family history of retinoblastoma who were screened from birth with dilation examinations had a much better chance of retaining their eyesight than nonscreened patients with similar histories.

But in 60 percent of cases, retinoblastoma develops for no known reason. Joey Bergsma of Lake Worth, Fla., was three years old when he died of the disease. 'We're never going to know just how long he had it,' says Bergsma's grandmother, Pam. Although photographs taken of the boy showed obvious signs of leukocoria, his family was unfamiliar with the symptoms. With no history of the disease to alert his doctor, Joey was not diagnosed until after the cancer had spread.

Now Pam Bergsma is pushing for legislation to require an eye dilation exam for all newborns, at all six- to eight-week well-baby exams, and at all six- to nine-month well-baby exams. She knows that the American Academy of Pediatrics (AAP) recommends 'red reflex' screening with an ophthalmoscope for all infants within their first two months, but only in a darkened room to maximize pupil dilation. It recommends medical dilation if anything looks askew.

The policy infuriates Bergsma. 'You only have a 30-percent chance of detection in an undilated eye,' she claims. The Retinoblastoma Center at the University of Southern California agrees. According to researchers there, an infant's pupil is so small that the detection of any intraocular condition is rare without pupil dilation.

But many doctors are hesitant to dilate an infant's eyes. 'Personally, I don't do it,' says Sarasota pediatrician Dr. Ted Meyers. If he spots anything unusual in a young patient, he refers them to a pediatric ophthalmologist.

'You can get some fairly significant medical complications [from dilation],' adds Meyers, who has practiced for 21 years. In 2003, the Florida Society of Ophthalmology (FSO) issued a statement citing hypertension, slow heart rates and behavioral disturbances as potential reactions from dilating agents. It claims that these side effects occur at a higher rate than retinoblastoma tumors, so dilation is not justified.

But opinions vary on just how many cases are seen in this country every year. The American Cancer Society says about 250 children are diagnosed with retinoblastoma annually, while the National Institutes of Health puts the number at 400. Other estimates range from 500 a year to one in 10,000. Doering saw more than 300 cases of retinoblastoma in the three years he spent at Cornell before moving to Sarasota last year.

Like all the doctors interviewed for this story, Doering hasn't treated a single case of retinoblastoma here. 'It's something that's more common in demographics with more children,' says Dr. Ronni Chen, a pediatric ophthalmologist at Kantor Eye Institute in Sarasota.

Bergsma counters that all childhood cancers are rare, compared to adult cancer, and that dilating an infant's eyes could ensure the detection of other retinal diseases that can be treated if detected early enough. Retinoblastoma tumors, for example, can be blasted away with a laser if caught in time.

Dr. Ronald Berkman, dean of Florida International University, claims the cost to Florida in direct and indirect costs for a blind child over the course of a lifetime can reach $2 million. 'The cost of the proposed screening is that for two drops of dilating solution and 10 seconds of a nurse's time,' he wrote in a letter to the Florida State Legislature urging passage of a newborn eye-screening bill.

Despite the American Academy of Pediatrics' policy on even minimal red reflex testing, fewer than 22 percent of all preschool children receive any type of vision screening at all. In 80 percent of the patients in the Cornell study, the disease was initially detected by the child's family or friends. Only 8 percent of the cases were discovered by pediatricians and only 10 percent by ophthalmologists.

The AOA reports that in a study of 102 private pediatric practices, doctors had screened just 38 percent of their three-year-old patients. A mere 26 percent of children who failed the American Academy of Pediatrics screening guidelines were subsequently referred for professional eye exams.

That's not good enough for Bergsma, who recounts stories of mothers who have been rebuffed by their pediatricians when they requested a formal exam, including one mother from Miami she met just last April. 'Why, four years after my grandson died, was I at the funeral of a little boy who died of the same thing?' she asks. 'This is just insane.'

RELATED ARTICLE: A REAL EYE-OPENER

If the thought of having the surface of your eye peeled back like a grape has kept you from enjoying the benefits of LASIK, think about IntraLase.

IntraLase replaces the handheld metal blade currently used in LASIK with the safety and precision of an ultra-fast laser, virtually eliminating blade-related complications, according to Dr. William J. Lahners, a board-certified ophthalmologist and LASIK surgeon and director of Vision Services at Sarasota's Center for Sight.

Traditional LASIK uses an oscillating metal razor, called a microkeratome, to create the corneal flap that is the first step in performing the procedure. InterLase fires a small pulse of light at 15,000 times per second, producing a series of miniscule bubbles that actually lift the cornea's surface. 'We don't actually cut or destroy anything,' says Lahners.

The result, according to one study of 375 eyes, is unprecedented accuracy and a significant reduction in injury to the eye. 'We end up with a flap that is exactly what we wanted,' adds Lahners. This is important, since most LASIK-related complications arise from cuts made to the cornea.

[ILLUSTRATION OMITTED]

IntraLase also seems to prevent a complication called surgically induced astigmatism. 'One of the limiting factors [of LASIK] was due to some of the distortions caused by the microkeratome flap,' Lahners explains. Because the cuts are irregular, 'They almost always add some degree of distortion.' IntraLase produces a flap that is even all the way around.

Currently, Center for Sight is one of only 10 vision centers in Florida offering the special laser, which has been FDA-approved for three years. Lahners says its expense adds about 10 percent to the cost of LASIK at Center for Sight, but says, 'Right now, one out of every eight LASIK procedures done in this country is being done with an IntraLase laser. It is very exciting technology.'

RELATED ARTICLE: WHEN TO SCREEN

After an initial screening at birth, the American Optometric Association recommends the following eye screening schedule.

суббота, 22 сентября 2012 г.

Annual eye exams beneficial in detecting vision problems related to diabetes - Michigan Chronicle


Michigan Chronicle
10-04-2005
It takes more than covering one eye, and then the other, to make sure your
eye-sight is good--especially for people with diabetes, according to Dr.
Donald G. Puro, an ophthalmologist at the University of Michigan's Kellogg
Eye Center in Ann Arbor.

'It's important for people to see their general medical doctor to be
screened for diabetes,' said Puro, who is also a member of the American
Diabetes Association. 'Too many people have diabetes and don't know it. If
they have diabetes, then they need to see an ophthalmologist, yearly, for
early changes that can occur with their vision.'

Diabetes is responsible for eight percent of legal blindness in the United
States. Each year, 12,000 to 24,000 people in this country lose their site
due to diabetes. The disease is the leading cause of new cases of blindness
in adults ages 20 to 74. Glaucoma, cataract and corneal disease are more
common in people with diabetes and contribute to the high rate of
blindness.

Nearly all patients who have Type 1 diabetes for about 20 years will have
evidence of diabetic retinopathy. And up to 21 percent of people with Type
2 diabetes have retinopathy when they are first diagnosed with diabetes.

Diabetic retinopathy--the major cause of blindness in people with
diabetes--is a term used for all the abnormalities of the small blood
vessels of the retina caused by diabetes, such as weakening of blood vessel
walls or leakage from blood vessels.

Retinopathy has two forms: non-proliferative retinopathy and proliferative
retinopathy. Non-proliferative retinopathy is common and usually mild, and
does not generally interfere with vision, unless abnormalities involve the
macula--the area on the retina that gives the sharpest vision. If left
untreated, it can progress to the more serious proliferative retinopathy
where new blood vessels branch out around the retina and can cause bleeding
in the fluid-filled center of the eye or swelling of the retina.

'Hemorrhaging can occur,' Puro said. 'The blood vessels also can incite
something like a scarring reaction in the eye and can pull the retina out
of place. That can lead to a complete loss of vision.

'The outside of the eye may look completely normal, but the stage could be
set for something to happen and the person wouldn't know it. You have to
dilate the pupil and look through the pupil to see the retina to see the
problem.'

The key to preventing diabetes-related eye problems is good control of
blood glucose levels, a healthy diet and good eye care, Puro added.

'Excellent control of blood sugar levels has been shown to slow down
diabetic retinopathy,' he said. 'Studies have proven that. The test is
hemoglobin A1C, which shows how good the control of diabetes has been for
the past three months. Below seven is the goal. But some people can have
levels of 11, 12 or 13 and that's very high risk.'

According to the American Diabetes Association, early detection is
important to reduce cases of blindness due to diabetes. Patient education,
health care team education and affordable eye care can make this possible,
but sometimes that is difficult in the African American community, Puro
said.

African Americans are twice as likely to suffer from diabetes-related
blindness as non-Hispanic whites.

'Many African Americans aren't plugged into the system as well as we would
like,' he said. 'Maybe they don't have health insurance or there are other
socioeconomic issues that prevent them from getting the yearly check of
things.'

Article copyright Michigan Chronicle Publishing Company, Inc.
V.69;

пятница, 21 сентября 2012 г.

GRANT SUPPORTS CHILDREN'S VISION HEALTH PROGRAMS - US Fed News Service, Including US State News

MORGANTOWN, W.

Va., Jan. 5 -- West Virginia University issued the following news release:

This The West Virginia University Eye Institute has received more than $40,000 in funding from The Greater Kanawha Valley Foundation in support of the Institute's crucial children's vision services in the Kanawha Valley region, an area that includes Boone, Clay, Fayette, Kanawha, Lincoln and Putnam counties.

The $41,018 grant award will benefit the WVU Eye Institute's Pediatric Vision Center and Rehabilitation Program. The Center offers treatment and rehabilitation services to Kanawha Valley area babies and children suffering from severe vision disorders, and to newborns diagnosed with Retinopathy of Prematurity, a potentially blinding condition.

In addition, the grant supports the WVU Eye Institute's Children's Vision Rehabilitation Program which provides blind and visually impaired school-aged children with tools to become independent and employable by optimizing visual function both at home and school. CVRP's mission is to provide access to the visual environment for children with incurable vision loss through medical eye care, optical devices, assistive technology, educational recommendations and support to local school systems. Children receive the clinic's services regardless of their family's ability to pay.

'We believe the Eye Institute provides one of the most valuable services in the health care arena,' said Becky Ceperley, TGKVF president and CEO. 'Helping those who are visually impaired prepare for a rich and full life is a priceless gift for those babies and children receiving the specialized treatment from the Institute. The Greater Kanawha Valley Foundation is proud to be able to support the work of the Eye Institute in some small way.'

The Greater Kanawha Valley Foundation is a public foundation that serves the citizens and charitable agencies of the Kanawha Valley by managing donations and appropriately distributing these funds to various organizations.

For more information about the programs and services of the WVU Eye Institute, see http://www.wvueye.com. For any query with respect to this article or any other content requirement, please contact Editor at htsyndication@hindustantimes.com

четверг, 20 сентября 2012 г.

Diabetes Alert Day Is March 27; Joslin Diabetes Center Reminds People With Diabetes to Schedule Annual Eye Exams to Preserve Vision. - AScribe Health News Service

Byline: Joslin Diabetes Center

BOSTON, March 23 (AScribe Newswire) -- Did you know that diabetes is the number one cause of preventable vision loss and blindness? Did you also know that an annual eye exam can lead to early detection of diabetic retinopathy and other eye disease, a frequent complication of diabetes?

On Diabetes Alert Day, March 27 -- a day set aside by the American Diabetes Association to raise public awareness of the rampant incidence of diabetes in our nation -- the care team at the world renowned Joslin Diabetes Center's Beetham Eye Institute reminds the 20.8 million Americans with diabetes to schedule an annual eye exam. Joslin's Beetham Eye Institute clinicians have shown that an annual exam can provide early detection and help prevent or delay 90 percent of cases of vision loss due to diabetic retinopathy. According to the Centers for Disease Control and Prevention, diabetic retinopathy is a leading cause of blindness in adults, resulting in 12,000 to 24,000 new cases of blindness each year.

Diabetic retinopathy, the most common eye disease in people with diabetes, occurs when the small blood vessels in the eye are damaged by high levels of glucose in the blood. Because diabetic retinopathy can progress to advanced stages without the patient knowing it, it is crucial to have annual eye exams to help preserve vision.

Joslin clinicians recommend a three-prong approach to preserving vision:

- Maintain excellent A1C levels. (The A1C is a test that measures average blood glucose levels over the 2 to 3 month period before the test.)

- Keep blood pressure, blood lipids and other health factors in check.

- Have an annual eye exam.

To watch a video on Joslin's Web site about the importance of annual eye exams, visit http://www.joslin.org/754_871.asp .

For more information about eye research and clinical trials at Joslin, visit http://www.joslin.org/755_3819.asp .

ABOUT THE BEETHAM EYE INSTITUTE: Joslin Diabetes Center's Beetham Eye Institute is a world leader in diabetes eye care and in research to identify the causes of diabetic eye disease and to find new therapies to lessen the risks of vision loss. The care team at the Beetham Eye Institute is dedicated to delivering the best and most personalized, compassionate care. For more information about Beetham Eye Institute services, visit http://www.joslin.org/754_871.asp . For an appointment, call (000)-000-0000.

ABOUT DIABETES: The World Health Organization reports that approximately 150 million people worldwide have diabetes, and the number is projected to double by the year 2025. In the United States, diabetes affects an estimated 20.8 million children and adults -- 7 percent of the population. An estimated 14.6 million Americans have been diagnosed, leaving 6.2 million Americans unaware that they have the disease. In addition, 54 million Americans are thought to have pre-diabetes, or elevated blood glucose levels that put them at risk for developing type 2 diabetes. If untreated or poorly treated, diabetes can lead to blindness, kidney disease, stroke, nerve damage and circulation problems that can result in limb amputations.

ABOUT JOSLIN DIABETES CENTER: Joslin Diabetes Center, dedicated to conquering diabetes in all of its forms, is the global leader in diabetes research, care and education. Founded in 1898, Joslin is an independent nonprofit institution affiliated with Harvard Medical School. Joslin research is a team of more than 300 people at the forefront of discovery aimed at preventing and curing diabetes. Joslin Clinic, affiliated with Beth Israel Deaconess Medical Center in Boston, the nationwide network of Joslin Affiliated Programs, and the hundreds of Joslin educational programs offered each year for clinicians, researchers and patients, enable Joslin to develop, implement and share innovations that immeasurably improve the lives of people with diabetes. As a nonprofit, Joslin benefits from the generosity of donors in advancing its mission. For more information on Joslin, call 1-800-JOSLIN-1 or visit http://www.joslin.org .

- - - -

Lighthouse International Expands Vision Health Services for All New Yorkers. - Diabetes Week

Responding to the growing number of New Yorkers who will need vision services, Lighthouse International, the 104-year-old trusted leader in vision health, opened VisionMax today, a comprehensive new vision healthcare center for all New Yorkers. VisionMax offers complete vision exams, prescriptions, contact lenses, designer frames and sunglasses as well as prevention and educational information (see also Lighthouse International).

According to Tara A. Cortes, Ph.D., RN, President and CEO of Lighthouse International, 'Vision health and prevention of vision loss are core to the work of the Lighthouse. This new service extends our reach to the many New Yorkers who will need our expertise as baby boomers age and more people have diabetes and other diseases that affect their eyesight.' According to Lighthouse International, about one million people (45 years and older) in the greater New York area will have will have vision loss by 2015. She adds, 'Vision health is more than a pair of eyeglasses. It includes a comprehensive eye exam, the lighting you read and work by, the foods you eat and the exercise you get. VisionMax will help New Yorkers maximize their vision for life.'

We gratefully acknowledge the generous donation of the JEMS Foundation in memory of Shirley Wegman. The donation enabled us to purchase a new state of the art diagnostic tool.

Conveniently located at 111 East 59th Street in midtown Manhattan, VisionMax includes the popular Lighthouse Store offering a wide range of useful products (from talking clocks to CCTVs). VisionMax also offers free seminars on diabetes and other vision-related diseases and vision health information.

VisionMax offers frames from such top designers as: Armani Exchange, Giorgio Armani, Marc Jacobs, Gucci, Dior, and more! Prices are competitive. Through April VisionMax offers a 15% discount on selected items.

VisionMax at Lighthouse International is located at 111 East 59th Street, New York City Hours: Eye exams and eyewear boutique: Monday to Friday, 9 a.m. - 5 p.m. For information and to make an appointment call 212-821-9620. The Lighthouse Store is open: Monday to Friday, 10 a.m. - 6 p.m. 212-821-9384.

Founded in 1905, Lighthouse International is a leading non-profit organization dedicated to fighting vision loss through prevention, treatment and empowerment. It achieves this through clinical and rehabilitation services, education, research and advocacy. For more information about vision health or vision loss and its causes, contact Lighthouse International at 1-800-829-0500 or visit www.lighthouse.org.

Keywords: Lighthouse International, Diabetes, Disease Prevention and Education, Medical Device, Contact Lens.

American Optometric Association Supports New Federal Health Report Findings: Vision Screening Methods for Seniors are Lacking. - Biotech Week

A report released by the U.S. Department of Health and Human Services through the Agency for Health Research and Quality (AHRQ) indicates that vision screenings, using standard methods of assessing visual acuity in older adults, a practice common in the primary care setting, is insufficient for use as a secondary prevention or screening method. The American Optometric Association (AOA) highlights the significance of the report as an important, evidence-based analysis that health care providers and aging Americans should carefully consider (see also American Optometric Association).

'The AHRQ findings support the importance of regular comprehensive eye examinations in older adults and highlight the importance of AOA's clinical care guidelines for older adults that stipulate the need for annual eye examinations in all adults age 61 or older,' said Michael R. Duenas, O.D., associate director of health sciences and policy at the AOA.

In addition, the AHRQ report found that screening for age-related eye diseases, many of which are asymptomatic in their early treatable stages, requires specialized examinations and equipment available through an optometrist or ophthalmologist.

'With the prevalence of adult vision impairment and age-related eye disease in America expected to double by 2030, the AHRQ findings offer a clear and distinct reason for all older adults to have a comprehensive eye examination on a regular basis,' said Randolph E. Brooks, O.D., president of the AOA.

In fact, the U.S. Centers for Disease Control and Prevention (CDC) reports that at least half of all blindness can be prevented through timely diagnosis and treatment. Furthermore, the CDC together with Prevent Blindness America (PBA) report that the annual economic cost of adult vision loss currently exceeds $51 billion dollars.

In addition, the CDC reports that the prevalence of blindness and vision impairment increases rapidly with age among all racial and ethnic groups. The agency's own data, Behavioral Risk Factor Surveillance System (BRFSS) indicates, however, that the vast majority of adults surveyed (60%) reported that they had 'no reason to have an eye exam.'

'Although aging is unavoidable, vision loss associated with aging is often preventable or treatable through regular eye examinations,' said Dr. Brooks. 'The AHRQ findings published sound an alarm to physicians and other health providers responsible for the health of seniors, to consider a comprehensive eye examination an essential component to necessary care. These eye examinations provide important information that may help uncover systemic disease, such as diabetes, thereby supporting a team approach to care.'

Keywords: American Optometric Association, Eye Disease, Aging.

среда, 19 сентября 2012 г.

TearScience Announces First U.S.-Based Eye Care Practice, Carolina Vision Center, to Offer LipiFlow[R] Treatment. - Health & Medicine Week

TearScience, Inc., a privately-held medical device company, announced that Fayetteville, North Carolina-based Carolina Vision Center, is the first eye care center in United States to commercially offer the LipiFlow[R] Thermal Pulsation System, a breakthrough treatment for evaporative dry eye disease. TearScience's LipiFlow is designed to address meibomian gland dysfunction, allowing for the treatment of eyelid gland blockages during a non-invasive procedure administered at an eye care office. Opening the blocked eyelid glands allows the glands to resume the natural production of lipids (oils) needed for a healthy tear film. TearScience received U.S. FDA clearance for its LipiFlow[R] medical device on June 28, 2011 (see also Eye Diseases).

'I am very pleased with the results since receiving the LipiFlow[R] treatment at Carolina Vision Center,' said Suzanne Hughes, a Raleigh resident and long time dry eye sufferer. 'My eyes are no longer red or itchy. The LipiFlow[R] treatment was painless. It felt like my eyes were being gently massaged with mild heat. I would highly recommend this treatment for those with chronic dry eye.'

Evaporative dry eye is caused by a deficiency in the lipid layer of the eye's natural tear film, resulting from blockages in the lipid-producing meibomian glands located in the eyelids, called meibomian gland dysfunction. A lipid deficiency can lead to evaporation of tears at a faster rate than normal, which can leave eyes feeling dry, irritated, tired and red. Of the more than 100 million dry eye sufferers worldwide, approximately 65 percent have evaporative dry eye.

'Carolina Vision Center prides itself on using the most advanced technology to provide excellent patient care,' said Dr. Michael Woodcock, founder at Carolina Vision Center. 'The LipiFlow[R] system provides us with an entirely new way to help a host of very frustrated dry eye patients. I was very impressed with the science behind the LipiFlow[R] and the clinical trial results. I'm delighted that we are the first in the U.S. to offer this advanced treatment.'

TearScience's technology platform is comprised of the LipiView[R] Ocular Surface Interferometer and the LipiFlow[R] Thermal Pulsation System. LipiView[R] allows physicians to visualize the tear film of patients with dry eye disease. LipiFlow[R] applies a precise combination of heat and pulsatile pressure to a patient's eyelids during a 12-minute in-office treatment, which is designed to alleviate meibomian gland blockages. 'We are very proud to work with Carolina Vision Center, one of the most innovative eye care centers on the east coast,' said Jeff O'Hara, vice president of North American sales for TearScience. 'This is a very exciting time for dry eye patients who now have a viable alternative to traditional dry eye treatments.' About TearScience, Inc. Headquartered in Morrisville, North Carolina, TearScience[R] has pioneered devices that provide significant clinical improvement in the treatment of evaporative dry eye. Of the more than 100 million dry eye sufferers worldwide, approximately 65 percent have evaporative dry eye, which is often caused by meibomian gland dysfunction (MGD) and a lipid deficiency of the eye's natural tear film. The Tear Film and Ocular Surface Society (TFOS) workshop, involving two years of work by 50 leading experts from around the world, concluded that MGD is an under-estimated condition and is very likely the most frequent cause of dry eye disease. TearScience's integrated, in-office system enables eye care professionals to effectively address a root cause of evaporative dry eye, obstructed meibomian glands. For additional information, visit www.TearScience.com. About Carolina Vision Center Carolina Vision Center serves its patients with the most advanced technology, the most skilled physicians and the most knowledgeable and caring staff. Carolina Vision Center specializes in dry eye, cataracts, macular degeneration, LASIK, glaucoma, and premium lenses. Dr. Michael Woodcock, the founder of Carolina Vision Center, has been involved in numerous clinical trials and has been voted on America's Top Ophthalmologist list each year since 2004.

Keywords: TearScience Inc..

Back-of-the-eye implant may improve vision - Ophthalmology Times

LEXINGTON, KY-An intravitreal fluocinolone implant may be a safe and effective treatment for diabetic macular edema (DME). Results from a pilot study indicated good improvement in visual acuity and resolution of retinal thickening, according to P. Andrew Pearson, MD.

'Laser photocoagulation effectively reduces the risk of vision loss resulting from diabetic macular edema, but it rarely improves vision,' said Dr. Pearson, associate professor of ophthalmology, University of Kentucky, Lexington. He is also director, Ophthalmic Research, Control Delivery Systems, a research company in Watertown, MA, that helped to develop the implant technology.

A public health issue

'Edema that is refractory to laser treatment remains a major public health issue and a source of frustration for patients and physicians. DME is a leading cause of blindness in the population under 65 years of age. There is no cutrently approved pharmacologic treatment,' Dr. Pearson said.

Because of this, he and his colleagues conducted the initial trial to test the safety and effectiveness of intravitreal fluocinolone implants to treat DME.

Some evidence exists, according to Dr. Pearson, that subTenon's injection of steroids has been effective in transiently improving macular edema. The possible mechanisms are that steroids inhibit vascular endothelial growth factor, which contributes to the development of macular edema. They also regulate tight junctions of endothelial cells, which decreases water and solute permeability.

'We hypothesized that intraocular delivery of steroids might decrease growth factors responsible for macular edema and stabilize the tight junctions, thus resulting in a two-pronged attack on the macular edema,' Dr. Pearson said.

Fluocinolone was selected as the treatment because of its low solubility and high potency, which allow the creation of a small intravitreal implant. Fluocinolone is also lipophilic and, therefore, remains in the posterior ocular segment, which may reduce ocular complications. It also breaks down rapidly, once in systemic circulation, which reduces the potential for systemic exposure, according to Dr. Pearson.

Dr. Pearson and colleagues developed an intravitreal implant that releases about 2 jig of the drug daily, which was expected to produce intravitreal concentrations of about 100 ng/ml. Implants containing 0.6 and 6 mg were also developed. All devices are designed to release drug for 3 years.

Five patients, who had DME that did not respond to one or two laser treatments, received the 6-mg device. One patient received a 2-mg implant.

'The implant is placed easily through a 3-mm sclerotomy with local anesthesia,' Dr. Pearson said.

The first patient to receive the implant had severe diffuse macular edema and a small area of neovascularization on the optic nerve; there were large cysts in the fovea. No laser treatment was apparent because of retinal thickening.

'Postoperatively, we observed resolution of the neovascularization and complete resolution of the macular edema,' he said. 'The laser scars were readily apparent because the retinal thickening resolved. Nine months after implantation, the treatment effect persisted.'

In the other patients with the device implanted, similar results were achieved.

The patients' visual acuity also improved by an average of eight letters by 3 months and 14 letters by 6 and 9 months postoperatively. The average visual acuity preoperatively was 20/158 and postoperatively 20/82. In patients who had vision worse than 20/100, vision improved an average of 19 letters.

The complications included mild intravitreal hemorrhaging at the time of implantation that did not affect vision. All patients with the 6-mg device implanted had an increase in IOP that responded to topical treatment. The patient with the 2-mg implant developed a mild increase in IOP that was left untreated. One patient developed a progressive subcapsular cataract.

'The fluocinolone insert may be a promising treatment for DME. It resuits in resolution of retinal thickening and in this small study a dramatic improvement in some patients,' Dr. Pearson said.

'The side effects and complications are of concern, but they may be acceptable considering the severity of the disease. A large four-center study is under way,' he concluded.